$79.00
Higher-dose HGH-derived fat-targeting peptide for extended research capacity per vial.
AOD 9604 10mg provides researchers with a larger quantity of this GH-fragment peptide per vial. Originally developed as an anti-obesity drug candidate, preclinical studies suggest AOD 9604 may mimic the fat-metabolising effects of growth hormone while carrying a safer metabolic profile. Nexopep’s 10mg format is lyophilised and third-party tested for purity and identity, suitable for longer-duration in-vitro studies or high-throughput research protocols. For research use only.
Reviews
There are no reviews yet.